Skip to main content
DaehanPharmaceutical logo

DaehanPharmaceutical — Investor Relations & Filings

Ticker · 023910 ISIN · KR7023910003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2023-12-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 023910

About DaehanPharmaceutical

https://www.dhnp.co.kr/

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by Mirae Asset Global Investments regarding their stake in Daehan Pharmaceutical Co., Ltd. This type of filing is a regulatory requirement in South Korea (under the Capital Markets Act) when an entity's shareholding crosses certain thresholds (typically 5%). It details the number of shares held, changes in ownership, and the purpose of the holding (in this case, simple investment). This fits the definition of a 'Major Shareholding Notification'.
2023-12-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details share transactions (acquisitions) by a director/major shareholder (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2023-11-21 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for '대한약품공업주식회사' (Daihan Pharm Co., Ltd.) covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, business operations, management discussion, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details share acquisitions by an executive (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is a standard disclosure for insider trading or changes in shareholding by company directors/executives, which corresponds to the 'Director's Dealing' category.
2023-11-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for insiders (directors/major shareholders) to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category.
2023-11-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the share ownership of Fidelity Management & Research Company LLC in 'Daehan Pharmaceutical Co., Ltd.' and includes information on special related parties and changes in shareholdings. This fits the definition of a Major Shareholding Notification.
2023-10-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.